RACHEL SOUTHARD: Open Payments
NPI 1669809604 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,116 in 48 payments from 19 companies in 2025. Trend: 2023 $451 · 2024 $860 · 2025 $1,116
Food & beverage: $1,116
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $146 |
| Novo Nordisk Inc | 5 | $125 |
| AstraZeneca Pharmaceuticals LP | 5 | $121 |
| GlaxoSmithKline, LLC. | 4 | $105 |
| Lilly USA, LLC | 4 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $94 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $62 |
| Actelion Pharmaceuticals US, Inc. | 2 | $56 |
| Exact Sciences Corporation | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
Products named: TRINTELLIX, BREZTRI, UBRELVY, MOUNJARO, XIFAXAN, TRELEGY ELLIPTA, OPSUMIT, Wegovy.
Industry payments across MA — which companies pay providers there.
